Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1996 2
1997 1
1998 2
1999 2
2001 1
2004 2
2005 3
2006 4
2007 2
2008 4
2010 2
2011 3
2012 2
2013 4
2014 1
2015 3
2016 3
2017 4
2018 3
2019 6
2020 3
2021 5
2022 7
2023 7
2024 4
2025 11
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

86 results

Results by year

Filters applied: . Clear all
Page 1
Trial of Anti-BDCA2 Antibody Litifilimab for Cutaneous Lupus Erythematosus.
Werth VP, Furie RA, Romero-Diaz J, Navarra S, Kalunian K, van Vollenhoven RF, Nyberg F, Kaffenberger BH, Sheikh SZ, Radunovic G, Huang X, Clark G, Carroll H, Naik H, Gaudreault F, Meyers A, Barbey C, Musselli C, Franchimont N; LILAC Trial Investigators. Werth VP, et al. N Engl J Med. 2022 Jul 28;387(4):321-331. doi: 10.1056/NEJMoa2118024. N Engl J Med. 2022. PMID: 35939578 Clinical Trial.
Trial of Anti-BDCA2 Antibody Litifilimab for Systemic Lupus Erythematosus.
Furie RA, van Vollenhoven RF, Kalunian K, Navarra S, Romero-Diaz J, Werth VP, Huang X, Clark G, Carroll H, Meyers A, Musselli C, Barbey C, Franchimont N; LILAC Trial Investigators. Furie RA, et al. N Engl J Med. 2022 Sep 8;387(10):894-904. doi: 10.1056/NEJMoa2118025. N Engl J Med. 2022. PMID: 36069871 Clinical Trial.
Phase 2 Trial of Iberdomide in Systemic Lupus Erythematosus.
Merrill JT, Werth VP, Furie R, van Vollenhoven R, Dörner T, Petronijevic M, Velasco J, Majdan M, Irazoque-Palazuelos F, Weiswasser M, Korish S, Ye Y, Gaudy A, Schafer PH, Liu Z, Agafonova N, Delev N. Merrill JT, et al. Among authors: petronijevic m. N Engl J Med. 2022 Mar 17;386(11):1034-1045. doi: 10.1056/NEJMoa2106535. N Engl J Med. 2022. PMID: 35294813 Clinical Trial.
Trophoblast Cell Function in the Antiphospholipid Syndrome.
Vrzić Petronijević S, Vilotić A, Bojić-Trbojević Ž, Kostić S, Petronijević M, Vićovac L, Jovanović Krivokuća M. Vrzić Petronijević S, et al. Among authors: petronijevic m. Biomedicines. 2023 Sep 30;11(10):2681. doi: 10.3390/biomedicines11102681. Biomedicines. 2023. PMID: 37893055 Free PMC article. Review.
A point of view on hereditary thrombophilia and low-molecular-weight heparin incorporating the management in pregnancy and involving thyroidology.
Dugalić S, Todorović J, Macura M, Petronijević SV, Petronijević M, Gojnić M, Sengul D, Sengul I, Pelikán A, Veiga ECA. Dugalić S, et al. Among authors: petronijevic m. Rev Assoc Med Bras (1992). 2023 Sep 18;69(9):e20230735. doi: 10.1590/1806-9282.20230735. eCollection 2023. Rev Assoc Med Bras (1992). 2023. PMID: 37729383 Free PMC article. No abstract available.
Association of circulating levels of anti-CarP antibodies with disease activity, disability and radiological damage in rheumatoid arthritis patients: an open-label, observational study.
Markovic M, Campochiaro C, Glisic B, Petronijevic M, Ristic G, Stanojevic I, Vojvodic D, Viapiana N, Matucci-Cerinic M, Dagna L. Markovic M, et al. Among authors: petronijevic m. Sci Rep. 2025 May 26;15(1):18325. doi: 10.1038/s41598-025-03464-z. Sci Rep. 2025. PMID: 40419667 Free PMC article.
Correction to: Endorsement by Central European experts of the revised ESCEO algorithm for the management of knee osteoarthritis.
Kucharz EJ, Szántó S, Ivanova Goycheva M, Petronijević M, Šimnovec K, Domżalski M, Gallelli L, Kamenov Z, Konstantynowicz J, Radunović G, Šteňo B, Stoilov R, Stok R, Vrana R, Bruyère O, Cooper C, Reginster JY. Kucharz EJ, et al. Among authors: petronijevic m. Rheumatol Int. 2019 Sep;39(9):1661-1662. doi: 10.1007/s00296-019-04347-z. Rheumatol Int. 2019. PMID: 31297562
Risk of suicide among oncologists in Serbia.
Randjelovic ND, Ignjatovic-Ristic DI, Petronijevic MV, Dugalic KZ. Randjelovic ND, et al. Among authors: petronijevic mv. Int J Psychiatry Med. 2025 Nov;60(6):681-697. doi: 10.1177/00912174251320720. Epub 2025 Feb 15. Int J Psychiatry Med. 2025. PMID: 39953945
86 results